Oak Grove Capital LLC Moderna, Inc. Transaction History

Oak Grove Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	SELL	$118.07 - $194.18 $66,945 - $110,100	-567 Reduced 24.06%	1,790 $212,000
Q2 2022 Aug 12, 2022	SELL	$117.13 - $176.59 $390,394 - $588,574	-3,333 Reduced 58.58%	2,357 $337,000
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $12,646 - $23,505	100 Added 1.79%	5,690 $980,000
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $214,529 - $350,084	950 Added 20.47%	5,590 $1.42 Million
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $97,636 - $213,166	440 Added 10.48%	4,640 $1.79 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $337,766 - $610,948	2,600 Added 162.5%	4,200 $987,000
Q1 2021 May 11, 2021	BUY	$109.18 - $185.98 $174,688 - $297,568	1,600 New	1,600 $210,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Oak Grove Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Grove Capital LLC with notifications on news.